Evidence-Based Medicine Guidelines
Losartan versus atenolol for diabetic hypertensive patients with LVH
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Losartan Versus Atenolol for Diabetic Hypertensive Patients With LVH." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452835/all/Losartan_versus_atenolol_for_diabetic_hypertensive_patients_with_LVH.
Losartan versus atenolol for diabetic hypertensive patients with LVH. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452835/all/Losartan_versus_atenolol_for_diabetic_hypertensive_patients_with_LVH. Accessed June 4, 2023.
Losartan versus atenolol for diabetic hypertensive patients with LVH. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452835/all/Losartan_versus_atenolol_for_diabetic_hypertensive_patients_with_LVH
Losartan Versus Atenolol for Diabetic Hypertensive Patients With LVH [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452835/all/Losartan_versus_atenolol_for_diabetic_hypertensive_patients_with_LVH.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Losartan versus atenolol for diabetic hypertensive patients with LVH
ID - 452835
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452835/all/Losartan_versus_atenolol_for_diabetic_hypertensive_patients_with_LVH
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
